{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:AKT",
      "entity_text" : "Akt",
      "entity_type" : "family"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0002620" ]
    }
  },
  "verbose_text" : "XREF_BIBR, XREF_BIBR However, we noted no differences in Akt phosphorylation between IGF-II-treated human skin fibroblasts from individuals with the p.Ile50Thr mutation and control subjects (XREF_SUPPLEMENTARY).",
  "reading_complete" : "2020-08-08T13:06:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T13:01:34Z",
  "trigger" : "phosphorylation",
  "evidence" : [ "Akt phosphorylation" ],
  "pmc_id" : "5339217",
  "score" : 0
}